Zydus Completes ₹84 Crore Buy of Sterling Biotech’s API Business
Zydus Lifesciences has closed its ₹84 crore purchase of Sterling Biotech’s API business, adding fermentation-based APIs and a plant near Vadodara.
Zydus Lifesciences has closed its ₹84 crore purchase of Sterling Biotech’s API business, adding fermentation-based APIs and a plant near Vadodara.
Zydus Lifesciences Limited, (including its subsidiaries and affiliates), an innovation-driven global lifesciences company, launched REVAHALE™ (Revefenacin), India’s first once-daily nebulised […]
Zydus Lifesciences has received approval from China’s National Medical Products Administration (NMPA) for Desidustat tablets, indicated for the treatment of […]
Zydus Lifesciences has launched a Denosumab biosimilar in India, expanding its oncology and biologics portfolio and strengthening access to bone-health […]
Indian origin pharmaceutical giant Zydus Lifesciences Limited has announced that it has received marketing authorisation from the National Medical Products […]
India’s Zydus Lifesciences has announced a major strategic acquisition, acquiring an 85.6% stake in French medical devices manufacturer Amplitude Surgical […]
In a significant development for the pharmaceutical industry, Zydus Lifesciences has received clearance from the US Food and Drug Administration […]
Zydus Lifesciences, a prominent player in the global healthcare sector, has unveiled Rexigo, the first-ever oral once-a-day therapy designed for […]